Approximately 10 percent of screened patients with visceral ... The patient was a 12-year-old boy who received 50 mg of miltefosine (2.8 mg per kilogram) daily. On day 6 of therapy, rash was ...

In addition, the single 10-mg dose of liposomal amphotericin B per ... A 28-day regimen of oral miltefosine and 21 days of once-daily intramuscular injections of paromomycin are also effective ...

with the 2.7% difference meeting both the prespecified noninferiority margin of 15% and the FDA's preferred margin of 10%, FDA reviewer Hala Shamsuddin, MD, said. Other data on miltefosine for VL ...

Please provide your email address to receive an email when new articles are posted on . N. fowleri lives in optimal water temperatures of 46oC (115oF). The amoeba can survive for extended periods ...

In this study supported by Zentaris, 299 patients at least 12 years of age received oral miltefosine, 50 or 100 mg daily (approximately 2.5 mg/kg) for 28 days, and 99 patients received 15 ...

June 28, 2017/PRNewswire/ -- Profounda, Inc. ("Profounda") announced today that it has received the US Food and Drug Administration's Orphan Drug Designation for the use of miltefosine to treat ...

A courier drove the drug, called miltefosine, six hours from the company's Orlando, Florida, headquarters to Charleston as soon as the hospital called around 10 p.m. Tuesday, Profounda CEO Todd ...

Called miltefosine, the experimental drug is not approved for use in the United States, but has been prescribed on a case by case basis to treat a parasitic infection called leishmaniasis ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...